Analgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin
1 other identifier
interventional
86
1 country
1
Brief Summary
Evaluation of the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 2, 2025
CompletedStudy Start
First participant enrolled
August 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
August 1, 2025
July 1, 2025
2.2 years
June 24, 2025
July 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
evaluate the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA.
asses pain postoperatively at 6,12,24 hours using VAS score
during the first 24 hours post-operatively
Secondary Outcomes (3)
assess the impact of pre-operative ketorolac and gabapentin on post-operative opioid consumption
during the first 24 hours post-operatively
investigate the safety profile of pre-operative ketorolac and gabapentin
during the first 24 hours post-operatively
evaluate the effect of pre-operative ketorolac and gabapentin on functional recovery
during the month after surgery
Study Arms (2)
Experimental group
ACTIVE COMPARATORExperimental group will receive single dose of gabapentin 800 mg capsule and ketorolac 30 mg Ampule, one hour prior to administration of spinal anesthesia
control group
PLACEBO COMPARATORcontrol group will receive normal saline ampule and empty capsule one hour prior to administration of spinal anesthesia
Interventions
a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded
a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded
Eligibility Criteria
You may qualify if:
- Patients Undergoing Unilateral Total Knee Replacement from 40 years old to 80 years old
You may not qualify if:
- Rheumatoid Arthritis History of Renal impairment Patients refused to be enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University, Faculty of Medicine
Asyut, Asyut Governorate, 71515, Egypt
Related Publications (4)
Skinner HB. Multimodal acute pain management. Am J Orthop (Belle Mead NJ). 2004 May;33(5 Suppl):5-9.
PMID: 15195936BACKGROUNDCapdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15. doi: 10.1097/00000542-199907000-00006.
PMID: 10422923BACKGROUNDHebl JR, Dilger JA, Byer DE, Kopp SL, Stevens SR, Pagnano MW, Hanssen AD, Horlocker TT. A pre-emptive multimodal pathway featuring peripheral nerve block improves perioperative outcomes after major orthopedic surgery. Reg Anesth Pain Med. 2008 Nov-Dec;33(6):510-7.
PMID: 19258965BACKGROUNDLee BH, Park JO, Suk KS, Kim TH, Lee HM, Park MS, Lee SH, Park S, Lee JY, Ko SK, Moon SH. Pre-emptive and multi-modal perioperative pain management may improve quality of life in patients undergoing spinal surgery. Pain Physician. 2013 May-Jun;16(3):E217-26.
PMID: 23703420BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hatem Mohamed Bakr, Professor
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 2, 2025
Study Start
August 15, 2025
Primary Completion (Estimated)
October 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
August 1, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share